Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Surrozen Inc., 3 years.
Surrozen Inc.
Director
Tango Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Tango Therapeutics Inc. June 4, 202679.9%
-
Surrozen Inc. May 13, 202684.4%
-
Tango Therapeutics Inc. June 6, 202396.6%
-
Surrozen Inc. May 18, 202378.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Tango Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Jun 5, 2025 | Tango Therapeutics Inc. | Grant or award | +6,250 | — | — |
| Nov 18, 2024 | Tango Therapeutics Inc. | Open-market purchase | +10,000 | $3.78 | $37,800 |
| Nov 14, 2024 | Tango Therapeutics Inc. | Open-market purchase | +10,000 | $3.62 | $36,200 |
| Jun 5, 2024 | Tango Therapeutics Inc. | Grant or award | +6,250 | — | — |
| Jun 6, 2023 | Tango Therapeutics Inc. | Grant or award | +5,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.